Please wait while we open this resource.
K
Clinical reviews
TIME TO QUADRUPLE GUIDELINE-DIRECTED MEDICAL THERAPY AS A KEY PERFORMANCE MEASURE FOR HEART FAILURE
null
PDF4 pages69 KB
The prevalence of heart failure (HF) is increasing, affecting over 64 million people worldwide. This document emphasizes the critical role of quadruple GDMT in improving survival rates and quality of life for patients with HFrEF. Despite strong clinical evidence and guidelines, the actual implementation of GDMT in clinical practice is suboptimal, with less than 25% of eligible patients receiving appropriate therapy. The authors analyze real-world patterns of GDMT initiation and highlight the need for improved adherence to treatment protocols.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE
Same clinical topic · Cardiology
PRACTICAL CARDIO-ONCOLOGY
Same clinical topic · Cardiology
OXFORD CARDIOLOGY LIBRARY: Hypertension
Same clinical topic · Cardiology
CARDIAC INVOLVEMENT IN PARASITIC INFECTIONS
Same clinical topic · Cardiology
The Athlete’s ECG
Same clinical topic · Cardiology
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review
Same clinical topic · Cardiology
Current ECG Aspects of Interatrial Block
Same clinical topic · Cardiology
Arrhythmic mitral valve prolapse in 2023: Evidence-based update
Same clinical topic · Cardiology
INTERPRETING THE NORMAL PACEMAKER
Same clinical topic · Cardiology